Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Non-cash Items: 2018-2021

Historic Non-cash Items for Whitehawk Therapeutics (WHWK) over the last 4 years, with Dec 2021 value amounting to $10.0 million.

  • Whitehawk Therapeutics' Non-cash Items was N/A to $539,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $539,000, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2021, which is 300.35% up from last year.
  • Whitehawk Therapeutics' Non-cash Items amounted to $10.0 million in FY2021, which was up 300.35% from $2.5 million recorded in FY2020.
  • In the past 5 years, Whitehawk Therapeutics' Non-cash Items ranged from a high of $10.0 million in FY2021 and a low of $142,788 during FY2018.
  • Over the past 3 years, Whitehawk Therapeutics' median Non-cash Items value was $2.9 million (recorded in 2019), while the average stood at $5.1 million.
  • In the last 5 years, Whitehawk Therapeutics' Non-cash Items soared by 1,959.41% in 2019 and then dropped by 15.00% in 2020.
  • Over the past 4 years, Whitehawk Therapeutics' Non-cash Items (Yearly) stood at $142,788 in 2018, then soared by 1,959.41% to $2.9 million in 2019, then decreased by 15.00% to $2.5 million in 2020, then spiked by 300.35% to $10.0 million in 2021.